LYVE1 and chondrosarcoma: In the tumor-induced lymphangiogenesis model, the IHC data revealed that knockdown of WISP-3 inhibited chondrosarcoma-promoted expression of WISP-3 and LEC markers VEGF-C and LYVE-1 (Figure 6E–I).